China’s biotech moment ignites a 60% stock rally that beats AI
China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and ...
China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and ...
Sanofi agreed to buy Blueprint Medicines for at least US$9.1 billion as the French drugmaker expands further in rare immunological ...
Biotechnology company Nuevocor announced on Wednesday (May 7) that it completed a US$45 million Series B funding round from new ...
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, tooMARKET watchers believe tax incentives proposed by the ...
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, tooMARKET watchers believe tax incentives proposed by the ...
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker ...
JOHNSON & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on treatments for central nervous ...
CHINESE conglomerate Fosun International will buy the remaining stake in Shanghai Henlius Biotech that it does not already own in ...
Dean's medal is Johns Hopkins Bloomberg School's highest honour.New Delhi: Dr Krishna Ella, co-founder and Executive Chairman of Bharat Biotech, ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2025 The New York Journals. All Rights Reserved.